Healthcare provider profile · identity verified

Christopher Lewis Wayne Finlay, MD

Family Practice · TEMPE, AZ · NPI 1538176912

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	620	187
Levothyroxine Sodium	Levothyroxine Sodium	430	120
Rosuvastatin Calcium	Rosuvastatin Calcium	369	110
Amlodipine Besylate	Amlodipine Besylate	358	102
Lisinopril	Lisinopril	303	91
Tamsulosin Hcl	Tamsulosin Hcl	252	81
Metformin Hcl	Metformin Hcl	248	74
Pantoprazole Sodium	Pantoprazole Sodium	226	68
Trazodone Hcl	Trazodone Hcl	219	60
Metoprolol Succinate	Metoprolol Succinate	212	61
Simvastatin	Simvastatin	196	53
Losartan Potassium	Losartan Potassium	177	57
Allopurinol	Allopurinol	169	46
Ozempic	Semaglutide	143	19
Omeprazole	Omeprazole	136	41
Gabapentin	Gabapentin	128	43
Hydrochlorothiazide	Hydrochlorothiazide	113	36
Escitalopram Oxalate	Escitalopram Oxalate	109	32
Pravastatin Sodium	Pravastatin Sodium	106	32
Doxycycline Monohydrate	Doxycycline Monohydrate	100	73
Zolpidem Tartrate	Zolpidem Tartrate	98	41
Sertraline Hcl	Sertraline Hcl	89	30
Albuterol Sulfate Hfa	Albuterol Sulfate	85	26
Clopidogrel	Clopidogrel Bisulfate	85	25
Eliquis	Apixaban	84	23
Fluoxetine Hcl	Fluoxetine Hcl	76	19
Alprazolam	Alprazolam	74	25
Finasteride	Finasteride	74	23
Citalopram Hbr	Citalopram Hydrobromide	73	19
Furosemide	Furosemide	72	23
Duloxetine Hcl	Duloxetine Hcl	66	19
Lorazepam	Lorazepam	61	21
Celecoxib	Celecoxib	59	19
Montelukast Sodium	Montelukast Sodium	56	18
Methylprednisolone	Methylprednisolone	53	42
Carvedilol	Carvedilol	52	17
Glimepiride	Glimepiride	52	13
Jardiance	Empagliflozin	51	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	14
Valacyclovir	Valacyclovir Hcl	50	21
Ipratropium Bromide	Ipratropium Bromide	47	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	15
Fluticasone Propionate	Fluticasone Propionate	44	19
Metoprolol Tartrate	Metoprolol Tartrate	44	15
Olmesartan Medoxomil	Olmesartan Medoxomil	43	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	12
Tramadol Hcl	Tramadol Hcl	42	13
Potassium Chloride	Potassium Chloride	41	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	19
Ezetimibe	Ezetimibe	37	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	11
Paxlovid	Nirmatrelvir/Ritonavir	36	33
Donepezil Hcl	Donepezil Hcl	35	suppressed
Famotidine	Famotidine	35	11
Lovastatin	Lovastatin	35	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	28
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	11
Spironolactone	Spironolactone	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Bupropion Xl	Bupropion Hcl	32	12
Synthroid	Levothyroxine Sodium	32	13
Trulicity	Dulaglutide	32	suppressed
Azithromycin	Azithromycin	28	26
Dutasteride	Dutasteride	27	suppressed
Meloxicam	Meloxicam	27	14
Valsartan	Valsartan	27	suppressed
Ramipril	Ramipril	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	17
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Amoxicillin	Amoxicillin	23	13
Clonazepam	Clonazepam	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Testosterone	Testosterone	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Cephalexin	Cephalexin	16	13
Estradiol	Estradiol	16	suppressed
Prednisone	Prednisone	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Baclofen	Baclofen	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Diazepam	Diazepam	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Atenolol	Atenolol	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error